Taieb V - Search Results

1

French Utility Elicitation in Previously Treated European Patients with Indolent Non-Hodgkin Lymphoma (INHL).

Bec M, Cognet M, Taieb V, Pacou M, Gauthier A. Bec M, et al. Among authors: taieb v. Value Health. 2014 Nov;17(7):A646. doi: 10.1016/j.jval.2014.08.2340. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202323 Free article. No abstract available.

2

A network meta-analysis to compare simeprevir with boceprevir and telaprevir in combination with peginterferon-α and ribavirin in patients infected with genotype 1 Hepatitis C virus.

Taieb V, Pacou M, Ho S, Pettré S, Van Sanden S, Pisini M, Ustianowski A, Mehnert A. Taieb V, et al. J Med Econ. 2015;18(10):787-96. doi: 10.3111/13696998.2015.1046880. Epub 2015 May 26. J Med Econ. 2015. PMID: 25934147 Free article.

3

Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?

Pacou M, Basso F, Gore C, Hass B, Taieb V, Cognet M, Pol S. Pacou M, et al. Among authors: taieb v. Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1063-8. doi: 10.1097/MEG.0000000000000410. Eur J Gastroenterol Hepatol. 2015. PMID: 26049711

4

Proposed Checklist for Non-Statisticians To Assess the Quality of A Network Meta-Analysis in the Context of A Nice Submission.

Pacou M, Gauthier A, Taieb V, Bec M, Belhadi D, Guillemot J. Pacou M, et al. Among authors: taieb v. Value Health. 2014 Nov;17(7):A579-80. doi: 10.1016/j.jval.2014.08.1960. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201949 Free article. No abstract available.

5

Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv).

Taieb V, Pacou M, Van Sanden S, Sbarigia U, Mehnert A, Duchesne I. Taieb V, et al. Value Health. 2014 Nov;17(7):A665. doi: 10.1016/j.jval.2014.08.2450. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202427 Free article. No abstract available.

6

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review.

Briere JB, Bowrin K, Coleman C, Fauchier L, Levy P, Folkerts K, Toumi M, Taieb V, Millier A, Wu O. Briere JB, et al. Among authors: taieb v. Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):27-36. doi: 10.1080/14737167.2018.1518134. Epub 2018 Sep 19. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 30169975

7

Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillation.

Briere JB, Bowrin K, Millier A, Toumi M, Wojciechowski P, Taieb V. Briere JB, et al. Among authors: taieb v. J Med Econ. 2019 Aug;22(8):760-765. doi: 10.1080/13696998.2019.1606001. Epub 2019 May 3. J Med Econ. 2019. PMID: 30969801 Free article.

8

A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients.

Taieb V, Ikeoka H, Ma FF, Borkowska K, Aballéa S, Tone K, Hirotsu N. Taieb V, et al. Curr Med Res Opin. 2019 Aug;35(8):1355-1364. doi: 10.1080/03007995.2019.1584505. Epub 2019 Apr 1. Curr Med Res Opin. 2019. PMID: 30810054 Free article.

9

Evaluating the costs of glycemic response with canagliflozin versus dapagliflozin and empagliflozin as add-on to metformin in patients with type 2 diabetes mellitus in the United Arab Emirates.

Schubert A, Buchholt AT, El Khoury AC, Kamal A, Taieb V. Schubert A, et al. Among authors: taieb v. Curr Med Res Opin. 2017 Jun;33(6):1155-1163. doi: 10.1080/03007995.2017.1310091. Epub 2017 Apr 28. Curr Med Res Opin. 2017. PMID: 28323512

10

Meta-analyses using real-world data to generate clinical and epidemiological evidence: a systematic literature review of existing recommendations.

Briere JB, Bowrin K, Taieb V, Millier A, Toumi M, Coleman C. Briere JB, et al. Among authors: taieb v. Curr Med Res Opin. 2018 Dec;34(12):2125-2130. doi: 10.1080/03007995.2018.1524751. Epub 2018 Sep 25. Curr Med Res Opin. 2018. PMID: 30217138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters